Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Price:
26.33
USD
-3.27%
Market Closed
Market Cap:
$3.5B
Balance Sheet
Balance Sheet Decomposition
Centessa Pharmaceuticals PLC
Centessa Pharmaceuticals PLC
Balance Sheet Decomposition is not available for
Centessa Pharmaceuticals PLC
Centessa Pharmaceuticals PLC
Balance Sheet
Centessa Pharmaceuticals PLC
Centessa Pharmaceuticals PLC
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
17
|
7
|
595
|
394
|
128
|
383
|
|
| Cash |
17
|
7
|
595
|
394
|
128
|
383
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
129
|
99
|
|
| Total Receivables |
2
|
3
|
17
|
27
|
39
|
45
|
|
| Other Current Assets |
1
|
1
|
17
|
17
|
19
|
9
|
|
| Total Current Assets |
19
|
11
|
629
|
438
|
315
|
536
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
13
|
12
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
13
|
12
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Note Receivable |
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
5
|
32
|
29
|
|
| Total Assets |
20
N/A
|
12
-41%
|
630
+5 281%
|
444
-29%
|
360
-19%
|
577
+60%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
1
|
8
|
14
|
12
|
7
|
|
| Accrued Liabilities |
0
|
1
|
16
|
23
|
27
|
50
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
5
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
2
|
0
|
1
|
|
| Total Current Liabilities |
2
|
9
|
25
|
38
|
39
|
58
|
|
| Long-Term Debt |
4
|
0
|
76
|
70
|
76
|
109
|
|
| Other Liabilities |
1
|
0
|
38
|
0
|
9
|
8
|
|
| Total Liabilities |
6
N/A
|
9
+41%
|
138
+1 506%
|
108
-22%
|
124
+15%
|
175
+41%
|
|
| Equity | |||||||
| Common Stock |
26
|
26
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
23
|
386
|
602
|
753
|
989
|
|
| Additional Paid In Capital |
0
|
0
|
876
|
939
|
987
|
1 386
|
|
| Other Equity |
1
|
0
|
1
|
2
|
1
|
4
|
|
| Total Equity |
14
N/A
|
3
-77%
|
492
+15 758%
|
336
-32%
|
236
-30%
|
402
+70%
|
|
| Total Liabilities & Equity |
20
N/A
|
12
-41%
|
630
+5 281%
|
444
-29%
|
360
-19%
|
577
+60%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
87
|
87
|
90
|
95
|
99
|
133
|
|
Switch to:
Switch to:
See Also
Discover More
